Total Payments
$17,194
2024 Payments
$2,713
Companies
62
Transactions
930
Medicare Patients
2,320
Medicare Billing
$400,603
Payment Breakdown by Category
Food & Beverage$17,006 (98.9%)
Education$163.81 (1.0%)
Other$24.35 (0.1%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $17,006 | 917 | 98.9% |
| Education | $163.81 | 12 | 1.0% |
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $24.35 | 1 | 0.1% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| UCB, Inc. | $2,876 | 113 | $0 (2024) |
| Sunovion Pharmaceuticals Inc. | $2,732 | 189 | $0 (2022) |
| ABBVIE INC. | $1,104 | 56 | $0 (2024) |
| SK Life Science, Inc. | $937.45 | 45 | $0 (2024) |
| Neurelis, Inc. | $882.78 | 52 | $0 (2024) |
| Eisai Inc. | $758.10 | 37 | $0 (2024) |
| Supernus Pharmaceuticals, Inc. | $755.60 | 51 | $0 (2023) |
| Lilly USA, LLC | $703.45 | 41 | $0 (2024) |
| LivaNova USA, Inc. | $546.08 | 40 | $0 (2024) |
| Lundbeck LLC | $457.44 | 24 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $2,713 | 114 | UCB, Inc. ($866.26) |
| 2023 | $1,939 | 95 | AbbVie Inc. ($355.75) |
| 2022 | $1,570 | 83 | ABBVIE INC. ($161.03) |
| 2021 | $2,997 | 162 | UCB, Inc. ($610.55) |
| 2020 | $1,441 | 94 | Sunovion Pharmaceuticals Inc. ($355.60) |
| 2019 | $2,432 | 143 | Sunovion Pharmaceuticals Inc. ($421.02) |
| 2018 | $1,788 | 112 | Sunovion Pharmaceuticals Inc. ($533.29) |
| 2017 | $2,314 | 127 | Sunovion Pharmaceuticals Inc. ($757.59) |
All Payment Transactions
930 individual payment records from CMS Open Payments — Page 1 of 38
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/19/2024 | Lilly USA, LLC | KISUNLA (Drug) | Food and Beverage | In-kind items and services | $23.04 | General |
| Category: Neuroscience | ||||||
| 12/18/2024 | SK Life Science, Inc. | — | Food and Beverage | In-kind items and services | $24.96 | General |
| 12/16/2024 | Alexion Pharmaceuticals, Inc. | ULTOMIRIS (Biological) | Food and Beverage | In-kind items and services | $33.73 | General |
| Category: Rare Disease | ||||||
| 12/14/2024 | Neurelis, Inc. | VALTOCO (Drug) | Food and Beverage | In-kind items and services | $23.50 | General |
| Category: EPILEPSY | ||||||
| 12/10/2024 | SK Life Science, Inc. | — | Food and Beverage | In-kind items and services | $78.03 | General |
| 12/09/2024 | JAZZ PHARMACEUTICALS INC. | EPIDIOLEX (Drug) | Food and Beverage | In-kind items and services | $45.83 | General |
| Category: NEUROLOGY | ||||||
| 12/08/2024 | SK Life Science, Inc. | — | Food and Beverage | In-kind items and services | $130.89 | General |
| 12/06/2024 | UCB, Inc. | — | Food and Beverage | In-kind items and services | $98.25 | General |
| 12/06/2024 | UCB, Inc. | Fintepla (Drug) | Food and Beverage | In-kind items and services | $89.51 | General |
| Category: Neurology | ||||||
| 12/05/2024 | Lilly USA, LLC | EMGALITY (Drug), REYVOW | Food and Beverage | In-kind items and services | $11.16 | General |
| Category: Neuroscience | ||||||
| 12/04/2024 | EMD Serono, Inc. | — | Food and Beverage | Cash or cash equivalent | $24.82 | General |
| 12/03/2024 | UCB, Inc. | Briviact (Drug) | Food and Beverage | In-kind items and services | $24.58 | General |
| Category: Neurology | ||||||
| 11/27/2024 | UCB, Inc. | Briviact (Drug) | Food and Beverage | In-kind items and services | $22.07 | General |
| Category: Neurology | ||||||
| 11/25/2024 | Eisai Inc. | Leqembi (Drug) | Food and Beverage | In-kind items and services | $26.80 | General |
| Category: Neurology | ||||||
| 11/21/2024 | Biogen, Inc. | LEQEMBI (Drug) | Food and Beverage | In-kind items and services | $13.73 | General |
| Category: Neurology | ||||||
| 11/20/2024 | Neurocrine Biosciences, Inc. | INGREZZA (Drug) | Food and Beverage | In-kind items and services | $16.67 | General |
| Category: Neuropsychiatry | ||||||
| 11/18/2024 | Alexion Pharmaceuticals, Inc. | ULTOMIRIS (Biological) | Education | In-kind items and services | $75.00 | General |
| Category: Rare Disease | ||||||
| 11/15/2024 | Lilly USA, LLC | EMGALITY (Drug), REYVOW | Food and Beverage | In-kind items and services | $27.16 | General |
| Category: Neuroscience | ||||||
| 11/12/2024 | ABBVIE INC. | BOTOX (Biological) | Food and Beverage | In-kind items and services | $10.15 | General |
| Category: BOTOX THERAPEUTIC | ||||||
| 11/05/2024 | Neurelis, Inc. | VALTOCO (Drug) | Food and Beverage | In-kind items and services | $36.83 | General |
| Category: EPILEPSY | ||||||
| 10/28/2024 | ABBVIE INC. | BOTOX (Biological) | Food and Beverage | In-kind items and services | $8.34 | General |
| Category: BOTOX THERAPEUTIC | ||||||
| 10/23/2024 | UCB, Inc. | Briviact (Drug) | Food and Beverage | In-kind items and services | $37.89 | General |
| Category: Neurology | ||||||
| 10/23/2024 | ABBVIE INC. | UBRELVY (Drug), QULIPTA | Food and Beverage | In-kind items and services | $23.43 | General |
| Category: NEUROSCIENCE | ||||||
| 10/18/2024 | ABBVIE INC. | QULIPTA (Drug), UBRELVY | Food and Beverage | In-kind items and services | $12.90 | General |
| Category: NEUROSCIENCE | ||||||
| 10/17/2024 | Eisai Inc. | Leqembi (Drug) | Food and Beverage | In-kind items and services | $26.40 | General |
| Category: Neurology | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 14 | 545 | 3,946 | $285,279 | $114,107 |
| 2022 | 14 | 585 | 842 | $245,816 | $97,957 |
| 2021 | 16 | 593 | 866 | $232,752 | $93,516 |
| 2020 | 19 | 597 | 787 | $253,851 | $95,024 |
Total Patients
2,320
Total Services
6,441
Medicare Billing
$400,603
Procedure Codes
67
All Medicare Procedures & Services
67 procedure records from CMS Medicare Utilization — Page 1 of 3
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 95708 | Measurement of brain wave activity (eeg), 12-26 hours | Office | 2023 | 45 | 76 | $44,200 | $19,811 | 44.8% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2023 | 86 | 122 | $45,628 | $17,593 | 38.6% |
| J0585 | Injection, onabotulinumtoxina, 1 unit | Office | 2023 | 12 | 3,290 | $39,480 | $15,987 | 40.5% |
| 95816 | Measurement of brain wave activity (eeg), awake and drowsy | Office | 2023 | 41 | 43 | $36,679 | $14,970 | 40.8% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 104 | 126 | $33,642 | $10,602 | 31.5% |
| 95700 | Measurement of brain wave activity (eeg), continuous | Office | 2023 | 42 | 42 | $18,900 | $9,729 | 51.5% |
| 99205 | New patient office or other outpatient visit, 60-74 minutes | Office | 2023 | 45 | 45 | $20,475 | $7,344 | 35.9% |
| 95886 | Needle measurement of electrical activity in arm or leg muscles, complete study | Office | 2023 | 44 | 67 | $14,668 | $5,826 | 39.7% |
| 95719 | Measurement of brain wave activity (eeg), 12-26 hours with health care professional review and report | Office | 2023 | 28 | 28 | $8,947 | $3,660 | 40.9% |
| 95723 | Measurement of brain wave activity (eeg), 61-84 hours with health care professional review and report | Office | 2023 | 12 | 12 | $6,264 | $2,522 | 40.3% |
| 64615 | Injection of chemical for paralysis of facial and neck nerve muscles on both sides of face | Office | 2023 | 12 | 17 | $5,950 | $2,169 | 36.4% |
| 95816 | Measurement of brain wave activity (eeg), awake and drowsy | Facility | 2023 | 34 | 35 | $4,064 | $1,591 | 39.2% |
| 95908 | Nerve conduction, 3-4 studies | Office | 2023 | 11 | 11 | $2,710 | $1,023 | 37.7% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 12 | 13 | $2,457 | $772.10 | 31.4% |
| G2212 | Prolonged office or other outpatient evaluation and management service(s) beyond the maximum required time of the primary procedure which has been selected using total time on the date of the primary service; each additional 15 minutes by the physician or | Office | 2023 | 17 | 19 | $1,216 | $507.89 | 41.8% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2022 | 113 | 175 | $51,386 | $24,567 | 47.8% |
| 95708 | Measurement of brain wave activity (eeg), 12-26 hours | Office | 2022 | 35 | 54 | $45,900 | $13,939 | 30.4% |
| 95816 | Measurement of brain wave activity (eeg), awake and drowsy | Office | 2022 | 36 | 37 | $29,391 | $12,506 | 42.5% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 99 | 126 | $27,197 | $11,773 | 43.3% |
| 99205 | New patient office or other outpatient visit, 60-74 minutes | Office | 2022 | 56 | 56 | $23,462 | $9,251 | 39.4% |
| 95886 | Needle measurement of electrical activity in arm or leg muscles, complete study | Office | 2022 | 44 | 73 | $13,486 | $6,463 | 47.9% |
| 99490 | Chronic care management services, first 20 minutes of clinical staff time directed by health care professional, per calendar month | Office | 2022 | 17 | 105 | $8,827 | $4,955 | 56.1% |
| 95719 | Measurement of brain wave activity (eeg), 12-26 hours with health care professional review and report | Office | 2022 | 24 | 27 | $8,213 | $3,585 | 43.7% |
| 95816 | Measurement of brain wave activity (eeg), awake and drowsy | Facility | 2022 | 61 | 61 | $6,600 | $2,859 | 43.3% |
| 95910 | Nerve conduction, 7-8 studies | Office | 2022 | 14 | 14 | $5,161 | $2,079 | 40.3% |
About Dr. Chunyang Wang, MD
Dr. Chunyang Wang, MD is a Electrodiagnostic Medicine healthcare provider based in Escondido, California. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 08/18/2008. The National Provider Identifier (NPI) number assigned to this provider is 1386890770.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Chunyang Wang, MD has received a total of $17,194 in payments from pharmaceutical and medical device companies, with $2,713 received in 2024. These payments were reported across 930 transactions from 62 companies. The most common payment nature is "Food and Beverage" ($17,006).
As a Medicare-enrolled provider, Wang has provided services to 2,320 Medicare beneficiaries, totaling 6,441 services with total Medicare billing of $400,603. Data is available for 4 years (2020–2023), covering 67 distinct procedure/service records.
Ad
Practice Information
- Specialty Electrodiagnostic Medicine
- Other Specialties Clinical Neurophysiology, Epilepsy
- Location Escondido, CA
- Active Since 08/18/2008
- Last Updated 09/10/2025
- Taxonomy Code 204R00000X
- Entity Type Individual
- NPI Number 1386890770
Products in Payments
- APTIOM (Drug) $2,827
- Briviact (Drug) $2,039
- UBRELVY (Drug) $1,039
- VALTOCO (Drug) $882.78
- VNS Therapy (Device) $664.04
- Fycompa (Drug) $653.74
- EMGALITY (Drug) $561.64
- TROKENDI XR (Drug) $512.72
- NUEDEXTA (Drug) $334.06
- Aimovig (Biological) $313.45
- Fintepla (Drug) $309.51
- QULIPTA (Drug) $307.43
- Epidiolex (Drug) $259.52
- AJOVY (Drug) $244.45
- OXTELLAR XR (Drug) $242.88
- Vimpat (Drug) $215.00
- NURTEC ODT (Drug) $213.25
- NUPLAZID (Drug) $207.50
- KYNMOBI (Drug) $207.21
- VYEPTI (Biological) $198.74
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.